NEVIRAPINE (VIRAMUNE)

Course overview

Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is U.S. FDA-approved to treat HIV-1 infections in patients ≥ 15 days old in combination with other antiretroviral agents. This continuing education module is designed to give the reader/learner an increased understanding of nevirapine. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.